Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration SRAS - Exploration (Accueil)

Index « Auteurs » - entrée « Naoki Yamamoto »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Naoki Masuda < Naoki Yamamoto < Naoko Iwata  Facettes :

List of bibliographic references indexed by Naoki Yamamoto

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
002114 (2011) Tohru Miyoshi-Akiyama [Japon] ; Isao Ishida ; Masaya Fukushi ; Keina Yamaguchi ; Yusuke Matsuoka ; Takashi Ishihara ; Masayoshi Tsukahara ; Seisuke Hatakeyama ; Norikazu Itoh ; Aki Morisawa ; Yoshiyuki Yoshinaka ; Naoki Yamamoto ; Zhang Lianfeng ; Qin Chuan ; Teruo Kirikae ; Takehiko SasazukiFully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model.
002374 (2011) Tohru Miyoshi-Akiyama [Japon] ; Isao Ishida [Japon] ; Masaya Fukushi [Japon] ; Keina Yamaguchi [Japon] ; Yusuke Matsuoka [Japon] ; Takashi Ishihara [Japon] ; Masayoshi Tsukahara [Japon] ; Seisuke Hatakeyama [Japon] ; Norikazu Itoh [Japon] ; Aki Morisawa [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Naoki Yamamoto [Japon] ; ZHANG LIANFENG [République populaire de Chine] ; QIN CHUAN [République populaire de Chine] ; Teruo Kirikae [Japon] ; Takehiko Sasazuki [Japon]Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model
002431 (2010) Shiori Haga [Japon] ; Noriyo Nagata ; Tadashi Okamura ; Norio Yamamoto ; Tetsutaro Sata ; Naoki Yamamoto ; Takehiko Sasazuki ; Yukihito IshizakaTACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds.
002917 (2010) Shiori Haga [Japon] ; Noriyo Nagata [Japon] ; Tadashi Okamura [Japon] ; Norio Yamamoto [Japon] ; Tetsutaro Sata [Japon] ; Naoki Yamamoto [Japon] ; Takehiko Sasazuki [Japon] ; Yukihito Ishizaka [Japon]TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
003075 (2008) Shiori Haga [Japon] ; Norio Yamamoto ; Chikako Nakai-Murakami ; Yoshiaki Osawa ; Kenzo Tokunaga ; Tetsutaro Sata ; Naoki Yamamoto ; Takehiko Sasazuki ; Yukihito IshizakaModulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry.
003103 (2008) Makoto Ujike [Japon] ; Hiroki Nishikawa ; Akira Otaka ; Naoki Yamamoto ; Norio Yamamoto ; Masao Matsuoka ; Eiichi Kodama ; Nobutaka Fujii ; Fumihiro TaguchiHeptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.
003519 (2008) Yu-Ya Mitsuki [Japon] ; Kazuo Ohnishi [Japon] ; Hirotaka Takagi [Japon] ; Masamichi Oshima [Japon] ; Takuya Yamamoto [Japon] ; Fuminori Mizukoshi [Japon] ; Kazutaka Terahara [Japon] ; Kazuo Kobayashi [Japon] ; Naoki Yamamoto [Japon] ; Shoji Yamaoka [Japon] ; Yasuko Tsunetsugu-Yokota [Japon]A single amino acid substitution in the Sl and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV
003B76 (2007) Masaji Okada [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Yoko Kita [Japon] ; Noriko Kanamaru [Japon] ; Yasuko Nishida [Japon] ; Yoshie Tsunai [Japon] ; Ruriko Inoue [Japon] ; Hitoshi Nakatani [Japon] ; Reiko Fukamizu [Japon] ; Yumi Namie [Japon] ; Junko Yamada [Japon] ; Kyoko Takao [Japon] ; Ritsuko Asai [Japon] ; Ryoko Asaki [Japon] ; Tetsuo Kase [Japon] ; Yuji Takemoto [Japon] ; Shigeto Yoshida [Japon] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
003F23 (2006) Masaji Okada [Japon] ; Yuji Takemoto ; Yoshinobu Okuno ; Satomi Hashimoto ; Yukari Fukunaga ; Takao Tanaka ; Yoko Kita ; Sechiko Kuwayama ; Yumiko Muraki ; Noriko Kanamaru ; Hiroko Takai ; Chika Okada ; Yayoi Sakaguchi ; Izumi Furukawa ; Kyoko Yamada ; Miwa Izumiya ; Shigeto Yoshida ; Makoto Matsumoto ; Tetsuo Kase ; J S M. Peiris ; Daphne E. Demello ; Pei-Jer Chen ; Naoki Yamamoto ; Yoshiyuki Yoshinaka ; Tatsuji Nomura ; Isao Ishida ; Shigeru Morikawa ; Masato Tashiro ; Mitsunori SakataniDevelopment of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models.
003F83 (2006) Shiro Shigeta [Japon] ; Shuichi Mori ; Toshihiro Yamase ; Norio Yamamoto ; Naoki YamamotoAnti-RNA virus activity of polyoxometalates.
004480 (2006) Shiro Shigeta [Japon] ; Shuichi Mori [Japon] ; Toshihiro Yamase [Japon] ; Norio Yamamoto [Japon] ; Naoki Yamamoto [Japon]Anti-RNA vims activity of polyoxometalates
004812 (2005) Yu Zhong [Japon] ; Yoshiyuki Yoshinaka ; Tadahiro Takeda ; Noriko Shimizu ; Sayaka Yoshizaki ; Yoshio Inagaki ; Shinobu Matsuda ; Gisho Honda ; Nobutaka Fujii ; Naoki YamamotoHighly potent anti-HIV-1 activity isolated from fermented Polygonum tinctorium Aiton.
004D45 (2005) Masaji Okada [Japon] ; Yuji Takemoto [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Shigeto Yoshida [Japon] ; Yukari Fukunaga [Japon] ; Takao Tanaka [Japon] ; Yoko Kita [Japon] ; Sachiko Kuwayama [Japon] ; Yumiko Muraki [Japon] ; Noriko Kanamaru [Japon] ; Hiroko Takai [Japon] ; Chika Okada [Japon] ; Yayoi Sakaguchi [Japon] ; Izumi Furukawa [Japon] ; Kyoko Yamada [Japon] ; Makoto Matsumoto [Japon] ; Tetsuo Kase [Japon] ; Daphne E. Demello [États-Unis] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
004E20 (2005) YU ZHONG [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Tadahiro Takeda [Japon] ; Noriko Shimizu [Japon] ; Sayaka Yoshizaki [Japon] ; Yoshio Inagaki [Japon] ; Shinobu Matsuda [Japon] ; Gisho Honda [Japon] ; Nobutaka Fujii [Japon] ; Naoki Yamamoto [Japon]Highly potent anti-HIV-1 activity isolated from fermented Polygonum tinctorium Aiton
005332 (2004) Norio Yamamoto [Japon] ; Rongge Yang [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Shinji Amari [Japon] ; Tatsuya Nakano [Japon] ; Jindrich Cinatl [Allemagne] ; Holger Rabenau [Allemagne] ; Hans Wilhelm Doerr [Allemagne] ; Gerhard Hunsmann [Allemagne] ; Akira Otaka [Japon] ; Hirokazu Tamamura [Japon] ; Nobutaka Fujii [Japon] ; Naoki Yamamoto [Japon]HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Naoki Yamamoto" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Naoki Yamamoto" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Naoki Yamamoto
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021